Injection Techniques for Medical Assistants: IM, SubQ, and Intradermal
InjectionsClinicalNHA CCMAProcedures
The Three Injection Routes
Medical assistants administer injections daily. Knowing which route, angle, needle gauge, and site to use is not just tested on your exam — it directly affects patient safety and medication effectiveness. The wrong depth can mean medication absorbed too fast, too slow, or not at all.
There are three parenteral injection routes you need to know: intramuscular (IM), subcutaneous (SubQ), and intradermal (ID). Each has a specific purpose and technique.
On the Exam: Injections fall within the Clinical Patient Care domain, which makes up 56% of the NHA CCMA exam. Expect questions on site selection, angle, gauge, volume, and technique. This topic also appears in medication administration and immunization questions.
Quick Comparison Table
Feature
Intramuscular (IM)
Subcutaneous (SubQ)
Intradermal (ID)
Angle
90°
45°
10–15°
Needle Gauge
21–23g
25–27g
25–27g
Volume
1–3 mL
0.5–1 mL
0.01–0.1 mL
Tissue depth
Muscle
Fatty (adipose) tissue
Dermis (between skin layers)
Absorption rate
Fast
Slow
Slowest (local only)
Intramuscular Injections
IM injections deliver medication deep into muscle tissue. Muscle has a good blood supply, so absorption is faster than SubQ. Medications given IM include many vaccines, B12, certain antibiotics, and testosterone.
IM Injection Sites
Deltoid: The preferred site for most adult vaccines. Located on the lateral aspect of the upper arm, about 2–3 finger-widths below the acromion process. Volume limited to 1 mL. Easy access, but smaller muscle mass.
Vastus Lateralis: The outer thigh muscle. Preferred for infants and toddlers who don't yet have developed deltoid or gluteal muscles. Can hold 1–3 mL. Accessible without repositioning the patient.
Ventrogluteal: The preferred gluteal site for adults. Located on the hip by placing the heel of your hand on the greater trochanter, pointing your index finger toward the anterior superior iliac spine, and spreading your middle finger posteriorly — inject in the V between the fingers. Less risk of hitting the sciatic nerve or major blood vessels than the dorsogluteal.
Dorsogluteal: The upper outer quadrant of the buttocks. Historically common but now discouraged due to proximity to the sciatic nerve and superior gluteal artery. Still appears on exams — know it but know the ventrogluteal is preferred.
Use a 1–1.5 inch needle for average adults. Obese patients may need 1.5–2 inch. Thin or pediatric patients may need 5/8 inch. Needle length matters — if it's too short, you'll inject into fat instead of muscle.
Z-Track Technique
Z-track is used for IM injections when the medication is irritating or when you want to prevent medication from leaking back into the subcutaneous tissue. Pull the skin 1–1.5 inches laterally with your non-dominant hand, inject at 90°, inject slowly, wait 10 seconds, withdraw the needle, then release the skin. The tissue shift creates a Z-shaped channel that seals off the injection path. Iron dextran is the classic example for Z-track.
Subcutaneous Injections
SubQ injections go into the fatty layer just below the skin. Absorption is slower than IM because adipose tissue has less blood supply. Common SubQ medications include insulin, heparin, and some vaccines like MMR and varicella.
Standard sites: upper outer arm, abdomen (at least 2 inches from the navel), anterior thigh, and upper buttocks. Rotate sites to prevent lipodystrophy — especially important for insulin-dependent patients who inject multiple times daily.
For very thin patients or with short needles (5/8 inch), you can inject at 90° instead of 45°. The goal is always to reach the subcutaneous layer without penetrating muscle.
Pinch up a fold of skin before inserting the needle. Release the skin fold before injecting the medication. Do not aspirate for routine SubQ injections.
Intradermal Injections
Intradermal injections go into the dermis — the layer just beneath the epidermis. The nearly flat angle (10–15°) is key. You're barely penetrating the skin. Volume is tiny: 0.01–0.1 mL.
The most common use is the tuberculin skin test (TST), also called the Mantoux test or PPD (purified protein derivative). The standard site is the inner (volar) forearm, about 4 finger-widths below the antecubital fold.
Insert with the bevel up, at 10–15°, until just the bevel is under the skin. Inject slowly. A pale, raised wheal (blister-like bump) should form — about 6–10 mm in diameter. If no wheal forms, you've injected too deep and need to restart at a new site.
The TST is read 48–72 hours after injection by measuring induration (hardness), not just redness.
Aspiration: The Current Guidance
Aspiration before injecting — pulling back the plunger to check for blood — was once standard practice for IM injections to confirm the needle wasn't in a blood vessel. Current CDC and WHO guidance no longer recommends routine aspiration for most IM or SubQ injections. Standard vaccine administration sites do not contain large blood vessels. Aspiration increases patient discomfort and injection time without meaningful safety benefit.
However, some facilities and providers still require it based on their protocols. Follow your workplace policy. Know both positions for your exam — questions may test whether you know the current evidence-based guidance.
Safety Needle Activation
All needles used in clinical settings should have engineered sharps injury protection — either a retractable needle or a sliding shield. Activate the safety mechanism immediately after withdrawing the needle from the patient, using a one-handed technique. Never recap a needle using two hands. Dispose of the entire syringe-and-needle unit directly into a sharps container. Never disassemble the needle from the syringe by hand.
Practice Questions
Question 1: A patient needs an IM injection using the Z-track method. Which of the following correctly describes this technique?
Answer: Pull the skin 1–1.5 inches to the side with your non-dominant hand, inject at 90°, wait 10 seconds before withdrawing, then release the skin. The Z-track prevents medication from leaking back through the injection track into subcutaneous tissue. It's used for irritating medications like iron dextran.
Question 2: You are administering a tuberculin skin test. At what angle should the needle be inserted?
Answer: 10–15 degrees. The intradermal route uses a nearly flat angle with the bevel up to deposit the medication in the dermis. A wheal should form. If the needle goes in at a steeper angle, it will miss the dermis and go into subcutaneous tissue, requiring a repeat test at a different site.
Question 3: Which IM injection site is preferred for adults and carries the lowest risk of sciatic nerve injury?
Answer: Ventrogluteal. The ventrogluteal site is the preferred gluteal injection site for adults. It is free of major nerves and blood vessels in the area used for injection. The dorsogluteal site is near the sciatic nerve and is no longer recommended as the first-choice site, though it remains in clinical use.
Question 4: After administering a SubQ injection, you should:
Answer: Activate the safety mechanism immediately and dispose of the entire unit in a sharps container. Do not recap needles with two hands. Do not remove the needle from the syringe manually. Aspiration is not required for routine SubQ injections per current guidance. Apply gentle pressure with a dry gauze — do not rub, as rubbing can cause tissue irritation.
Frequently Asked Questions
What gauge needle is used for IM injections?
21–23 gauge. Lower gauge numbers mean larger bore. SubQ and intradermal injections use 25–27 gauge, which is thinner.
How do I know if the wheal formed correctly for an intradermal injection?
A correct intradermal injection produces a pale raised wheal of 6–10 mm. If no wheal appears, the injection went too deep and a new site must be used.
Should I aspirate before an IM injection?
Current CDC and WHO guidance does not recommend routine aspiration for standard IM or SubQ sites. Follow your facility protocol and know the current evidence-based guidance for the exam.
Why do SubQ injection sites need to be rotated?
Repeated injections cause lipodystrophy — tissue changes that affect absorption. Rotating sites prevents this.
When is the tuberculin skin test read, and what are you looking for?
Read at 48–72 hours. Measure induration (hardness), not just redness. Positive thresholds vary by patient risk level.